Related Experiment Video
Updated: Jun 16, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia
Barbara Bauce1, Andrea Nava, Giorgia Beffagna
1Department of Cardiac-Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy.
Insights
Multiple mutations in desmosomal genes are relevant in arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D). Multiple-mutation carriers often exhibit more severe disease and left ventricular involvement compared to single-mutation carriers.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) presents a diverse clinical spectrum.
- Understanding genetic underpinnings is crucial for prognosis and management.
Purpose of the Study:
- To determine the frequency of compound and double heterozygotes for desmosomal gene mutations in Italian ARVC/D index cases.
- To evaluate the clinical phenotype associated with these multiple-mutation carriers.
Main Methods:
- Screening of 42 ARVC/D index cases for mutations in PKP2, DSP, DSG2, DSC2, and JUP genes.
- Utilized denaturing high-performance liquid chromatography (DHPLC) and direct sequencing for mutation detection.
Main Results:
- 7.1% of probands with a family history of sudden death carried multiple mutations.
- Multiple-mutation carriers showed increased left ventricular involvement (P = .025) compared to single-mutation carriers.
- Compound and double heterozygotes displayed variable clinical expressivity, with some severe cases and increased disease extent.
Conclusions:
- The presence of compound and double heterozygotes is significant for ARVC/D mutation screening and genetic counseling strategies.
- Multiple-mutation carriers, despite variable clinical presentation, tend to have a more extensive disease phenotype than single-mutation carriers.
Background:
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a progressive cardiomyopathy showing a wide clinical spectrum in terms of clinical expressions and prognoses.
Objective:
This study sought to estimate the occurrence of compound and double heterozygotes for mutations in desmosomal proteins encoding genes in a cohort of ARVC/D Italian index cases, and to assess the clinical phenotype of mutations carriers.
Methods:
Fourty-two consecutive ARVC/D index cases who fulfilled the International Task Force diagnostic criteria were screened for mutations in PKP2, DSP, DSG2, DSC2, and JUP genes by denaturing high-performance liquid chromatography (DHPLC) and direct sequencing.
Results:
Three probands (7.1%) showing a family history of sudden death carried multiple mutations. Family screening identified an additional 7 multiple-mutation carriers. Among the 7 double heterozygotes for mutations in different genes, 2 were clinically unaffected, 2 were affected, and 3 showed some clinical signs of ARVC/D even if they did not fulfill the diagnostic criteria. Two compound heterozygotes for mutations in the same gene and 1 subject carrying 3 different mutations showed a severe form of the disease with heart failure onset at a young age. Moreover, multiple-mutation carriers showed a higher prevalence of left ventricular involvement (P = .025) than single-mutation carriers.
Conclusion:
Occurrence of compound and double heterozygotes in ARVC/D index cases is particularly relevant to mutation screening strategy and to genetic counseling. Even if multiple-mutation carriers show a wide variability in clinical expression, the extent of the disease is higher compared to that in single-mutation carriers.
Related Concept Videos
Desmosomes
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy

